Trevena
TRVN
#10609
Rank
โ‚น0.93 M
Marketcap
โ‚น1.08
Share price
0.00%
Change (1 day)
-99.24%
Change (1 year)

Revenue for Trevena (TRVN)

Revenue in 2024 (TTM): โ‚น45.65 Million

According to Trevena's latest financial reports the company's current revenue (TTM ) is โ‚น49.05 Million. In 2023 the company made a revenue of โ‚น0.26 Billion an increase over the revenue in the year 2022 that were of -โ‚น34.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Trevena from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น45.65 M-82.45%
2023 โ‚น0.26 B-852.11%
2022 -โ‚น34.59 Million-181.96%
2021 โ‚น42.2 M-81.2%
2020 โ‚น0.22 B10053.09%
2019 โ‚น2.21 M-99.45%
2018 โ‚น0.40 B
2017 N/A-100%
2016 โ‚น0.25 B-38.65%
2015 โ‚น0.41 B
2014 N/A-100%
2013 โ‚น8.33 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚น3.231 T 6,587,995.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚น7.83 B 15,872.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
โ‚น0.64 B 1,207.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น5.770 T 11,764,552.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚น33.5 M-31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
โ‚น58.48 M 19.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚น9.01 B 18,288.28%๐Ÿ‡บ๐Ÿ‡ธ USA